Trodusquemine Inhibits Amyloid Oligomer Binding
Corresponding Organization :
Other organizations : University of Cambridge, University of Florence, United States Military Academy, Universidad de Zaragoza, Georgetown University
Variable analysis
- Presence or absence of HypF-N oligomers (6 µM)
- Presence or absence of Aβ40 oligomers (5 µM)
- Increasing concentrations of trodusquemine (10:1, 3:1, and 1:1 ratios of oligomers to trodusquemine, monomer equivalents)
- Presence of Aβ40 or HypF-N oligomers
- Percentage of oligomer colocalization
- SH-SY5Y cells seeded on glass coverslips
- Incubation time (15 min)
- PBS washing steps
- Alexa Fluor 633-conjugated wheat germ agglutinin staining (5.0 µg mL−1)
- Primary antibodies (1:800 dilution): mouse monoclonal 6E10 anti-Aβ antibodies, rabbit monoclonal anti-HypF-N antibodies
- Secondary antibodies (1:1000 dilution): Alexa Fluor 488-conjugated anti-mouse or anti-rabbit
- Absence of trodusquemine (oligomers only)
- Absence of oligomers (no treatment)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!